EUVIMEDEUVIMED entdecken
Crossref

Diversity Plans and Postmarketing Studies: First Impressions of Anticipated Diversity Requirements in the United States

Blake Schouest iD, Krithi Rao Bindal

Therapeutic Innovation & Regulatory Science · 2024

DOI: 10.1007/s43441-024-00643-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2024. Verfasst von Blake Schouest und 1 weiteren Autor:innen. Beteiligte Einrichtung: Aroga Biosciences, Inc, 10717 Sorrento Valley Road, San Diego, CA, 92121, USA. bschouest@arogabio.com. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Product Surveillance, Postmarketing. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

United States Food and Drug AdministrationProduct Surveillance, PostmarketingUnited StatesHumansSurveys and QuestionnairesEthnicityDrug DevelopmentDrug IndustryCultural DiversityRacial Groups

Stichwörter der Autor:innen

DiversityDiversity planEthnicityFood and Drug AdministrationPostmarketing studyRace

Autor:innen und Institutionen

  • Aroga Biosciences, Inc, 10717 Sorrento Valley Road, San Diego, CA, 92121, USA. bschouest@arogabio.com.
  • Aroga Biosciences, Inc, 10717 Sorrento Valley Road, San Diego, CA, 92121, USA.

ORCID-Profile: Blake Schouest

Zitieren

APA

Schouest, B., & Bindal, K. R. (2024). Diversity Plans and Postmarketing Studies: First Impressions of Anticipated Diversity Requirements in the United States. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00643-4

Vancouver

Schouest B, Bindal KR. Diversity Plans and Postmarketing Studies: First Impressions of Anticipated Diversity Requirements in the United States. Therapeutic Innovation & Regulatory Science. 2024. doi:10.1007/s43441-024-00643-4

BibTeX
@article{Schouest2024,
  author = {Schouest, Blake and Bindal, Krithi Rao},
  title = {Diversity Plans and Postmarketing Studies: First Impressions of Anticipated Diversity Requirements in the United States},
  journal = {Therapeutic Innovation & Regulatory Science},
  year = {2024},
  doi = {10.1007/s43441-024-00643-4}
}
Kostenlos starten →